Syndax Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Good morning, and thank you for joining us today. My name is [Andrew Lang], and I'm an analyst in JPMorgan's health care group.
Before I introduce you to our presenters today, I want to call your attention to the blue ask a question button on your screen. This is where you'll submit questions that will be addressed at the end during the Q&A session.
With that, I am pleased to introduce you to the Syndax team here today. Briggs Morrison, CEO; Michael Metzger, President and COO; and Anjali Ganguli, CBO. I know they're very excited to tell you a little bit more about their story. So we'll turn it over to them.
Great. Thank you so much, Andrew, and welcome and thank you to those of you joining us on the line this morning for a summary of our current corporate priorities as we strive to realize a future in which people with cancer live longer and better than ever before.
I'm Briggs Morrison, CEO of Syndax. This call is being accompanied by a slide
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |